ArticleBlood cell therapy2026
Menstrual patterns and gonado-sexual health following hematopoietic transplant in reproductive age women and the role of hormone replacement therapy.
Article in Blood cell therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Menstrual patterns, reproductive sequelae, sexual health, and the role of hormone replacement therapy (HRT) among women following hematopoietic stem cell transplantation (HSCT) remain underexplored. This study evaluated menstrual resumption, ovarian reserve, fertility outcomes, sexual function, and attitudes towards HRT among women who underwent HSCT. Methods: This single-centre retrospective, cross-sectional analysis included women aged 18-45 years who had undergone HSCT for haematological malignancies and were on follow-up of at least 6 months post-HSCT. Data collected encompassed demographic details, disease characteristics, prior treatments, and transplant details. Menstrual patterns, anti-Müllerian hormone (AMH) levels, antral follicular counts (AFC), and the female sexual function index (FSFI) were measured among HSCT recipients at the time of study recruitment and compared with 30 age-matched healthy controls. Women with premature ovarian insufficiency (amenorrhea and follicle stimulating hormone [FSH] > 40 IU/L) were offered HRT. Among women who were administered HRT, 6 months follow-up menstrual resumption rates and FSFI assessments were done. Results: Among the 30 women enrolled, 86.6% (26/30) of patients had normal menstruation pre-HSCT, which declined to 23% (7/30) post-HSCT ( Conclusions: Ovarian and sexual dysfunction are frequent in post-HSCT women; a subset resumes spontaneous menstruation. Spontaneous conceptions may be observed despite low ovarian reserve markers. HRT may have a potential role to improve sexual and menstrual functions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.